AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...
One year ago, Tim Andrews was among the world’s first recipients of a genetically modified pig kidney. Now, he is the first in that small group of pioneers to go on to receive a human kidney.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback